| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8672312 | Journal of Vascular Surgery | 2017 | 6 Pages |
Abstract
Cryopreserved allograft provides an excellent conduit for angioaccess when autogenous tissue is not available in patients with current or past conduit infection. Cryopreserved vein was associated with higher patency and a lower cost per day of graft patency. Cryopreserved allograft allows for immediate reconstruction through areas of infection, reduces the need for staged procedures, and allows early use for dialysis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael P. MPH, Peter F. MD, Aamna MD, Esther DO, James MD, Christopher MD, Michael MD, Gary W. MD, Sotero MD, Jeffrey MD, The Vascular Low-Frequency Disease Consortium The Vascular Low-Frequency Disease Consortium,